IMMUNOFLUORESCENCE OF MINERALOCORTICOID RECEPTORS IN PERIPHERAL LYMPHOCYTES - PRESENCE OF RECEPTOR-LIKE ACTIVITY IN PATIENTS WITH THE AUTOSOMAL-DOMINANT FORM OF PSEUDOHYPOALDOSTERONISM, AND ITS ABSENCE IN THE RECESSIVE FORM
U. Kuhnle et al., IMMUNOFLUORESCENCE OF MINERALOCORTICOID RECEPTORS IN PERIPHERAL LYMPHOCYTES - PRESENCE OF RECEPTOR-LIKE ACTIVITY IN PATIENTS WITH THE AUTOSOMAL-DOMINANT FORM OF PSEUDOHYPOALDOSTERONISM, AND ITS ABSENCE IN THE RECESSIVE FORM, Journal of steroid biochemistry and molecular biology, 51(5-6), 1994, pp. 267-273
Pseudohypoaldosteronism is a syndrome characterized by salt wasting an
d a failure to thrive due to the resistance towards the action of aldo
sterone. Aldosterone levels and plasma renin activity are extremely el
evated and aldosterone binding sites in peripheral mononuclear leukocy
tes have regularly shown to be reduced or absent. Sporadic as well as
familial cases have been identified and an autosomal dominant as well
as an autosomal recessive mode of inheritance has been described. A de
fect in the aldosterone receptor has been postulated, however, molecul
ar genetic analysis in selected patients has not revealed a mutation i
n the sequence of the coding region of the cDNA of the mineralocortico
id receptor gene. In the present study we have used a fluorescence-lab
eled antibody to detect possible receptor expression in monocytes from
patients with various clinical forms of pseudohypoaldosteronism. Pati
ents with the sporadic as well as with the autosomal dominant form wer
e clearly immunopositive despite being negative in terms of aldosteron
e receptor binding. In contrast in two patients with the autosomal rec
essive form there was no detectable receptor protein, consistent with
the results obtained in the aldosterone binding studies. These results
suggest that the pathogenesis of pseudohypoaldosteronism is heterogen
eous not only regarding the mode of inheritance but also in terms of r
eceptor binding. Thus, in a subgroup of patients the inability of the
receptor to bind ligand may be due to a defect involving other, probab
ly cellular factors rather than a deficiency or a defect in the minera
locorticoid receptor system itself.